Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
A role for TNF-α in alveolar macrophage damage-associated molecular pattern release
Morgan K. Collins, Abigail M. Shotland, Morgan F. Wade, Shaikh M. Atif, Denay K. Richards, Manolo Torres-Llompart, Douglas G. Mack, Allison K. Martin, Andrew P. Fontenot, Amy S. McKee
Morgan K. Collins, Abigail M. Shotland, Morgan F. Wade, Shaikh M. Atif, Denay K. Richards, Manolo Torres-Llompart, Douglas G. Mack, Allison K. Martin, Andrew P. Fontenot, Amy S. McKee
View: Text | PDF
Research Article Immunology

A role for TNF-α in alveolar macrophage damage-associated molecular pattern release

  • Text
  • PDF
Abstract

Chronic beryllium disease (CBD) is a metal hypersensitivity/autoimmune disease in which damage-associated molecular patterns (DAMPs) promote a break in T cell tolerance and expansion of Be2+/self-peptide–reactive CD4+ T cells. In this study, we investigated the mechanism of cell death induced by beryllium particles in alveolar macrophages (AMs) and its impact on DAMP release. We found that phagocytosis of Be led to AM cell death independent of caspase, receptor-interacting protein kinases 1 and 3, or ROS activity. Before cell death, Be-exposed AMs secreted TNF-α that boosted intracellular stores of IL-1α followed by caspase-8–dependent fragmentation of DNA. IL-1α and nucleosomal DNA were subsequently released from AMs upon loss of plasma membrane integrity. In contrast, necrotic AMs released only unfragmented DNA and necroptotic AMs released only IL-1α. In mice exposed to Be, TNF-α promoted release of DAMPs and was required for the mobilization of immunogenic DCs, the expansion of Be-reactive CD4+ T cells, and pulmonary inflammation in a mouse model of CBD. Thus, early autocrine effects of particle-induced TNF-α on AMs led to a break in peripheral tolerance. This potentially novel mechanism may underlie the known relationship between fine particle inhalation, TNF-α, and loss of peripheral tolerance in T cell–mediated autoimmune disease and hypersensitivities.

Authors

Morgan K. Collins, Abigail M. Shotland, Morgan F. Wade, Shaikh M. Atif, Denay K. Richards, Manolo Torres-Llompart, Douglas G. Mack, Allison K. Martin, Andrew P. Fontenot, Amy S. McKee

×

Figure 7

Be-induced DAMP release, pulmonary inflammation, and mobilization of immunogenic cDCs from the lung to the LDLNs are impaired in TNF-α–KO mice.

Options: View larger image (or click on image) Download as PowerPoint
Be-induced DAMP release, pulmonary inflammation, and mobilization of imm...
(A and B) B6 WT and TNF-α–KO mice were exposed i.t. to nothing (0 hours exposed) or to 50 μg Be i.t. At the indicated times after exposure, BAL cells were analyzed as described in Figure 6A. (A) Concentrations of DNA and IL-1α detected in the BALF are shown. (B) Total number of neutrophils/BAL are shown for each time point. (C and D) B6 WT and TNF-α–KO mice were exposed i.t. to PBS ± 50 μg Be i.t. for 48 hours. LDLNs were analyzed as described in Figure 6C. (C) Total migratory cDCs per lymph node (LN) and total number of CD11bhi and CD103hi DCs/LN are shown. (D) Total CD80hi cDCs/LN are shown for each treatment group. Data are combined from 2 independent experiments (n = 8 mice group in A and B; n = 9 mice/group in C and D). Symbols on graphs indicate values from individual mice; bars indicate means ± SEM. A 1-way ANOVA was used to test for statistical differences between indicated groups. Statistical P values for selected comparisons are indicated as *P < 0.05; **P < 0.01; ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts